Imaging genomics in cancer research: limitations and promises.

Recently, radiogenomics or imaging genomics has emerged as a novel high-throughput method of associating imaging features with genomic data. Radiogenomics has the potential to provide comprehensive intratumour, intertumour and peritumour information non-invasively. This review article summarizes the current state of radiogenomic research in tumour characterization, discusses some of its limitations and promises and projects its future directions. Semi-radiogenomic studies that relate specific gene expressions to imaging features will also be briefly reviewed.

[1]  Massimo Loda,et al.  Investigative pathology: leading the post-genomic revolution , 2012, Laboratory Investigation.

[2]  Marit Holden,et al.  Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. , 2012, Cancer research.

[3]  Chaya S Moskowitz,et al.  Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? , 2014, Lung cancer.

[4]  A. Rutman,et al.  A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma , 2015, Hepatology.

[5]  Subha Madhavan,et al.  NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures , 2014, Translational oncology.

[6]  Insuk Sohn,et al.  Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach , 2015, Medicine.

[7]  Paul S Mischel,et al.  Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. , 2008, Radiology.

[8]  Michael D. Feldman,et al.  A Multichannel Markov Random Field Approach for Automated Segmentation of Breast Cancer Tumor in DCE-MRI Data Using Kinetic Observation Model , 2011, MICCAI.

[9]  Sanjeev Chawla,et al.  Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma. , 2012, Neuro-oncology.

[10]  Lawrence H. Schwartz,et al.  Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes. , 2013, Radiology.

[11]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[12]  William D. Dunn,et al.  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. , 2013, Radiology.

[13]  Olivier Gevaert,et al.  Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. , 2012, Cancer research.

[14]  S. Horvath,et al.  Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2 , 2007, Clinical Cancer Research.

[15]  Luke Macyszyn,et al.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. , 2016, Neuro-oncology.

[16]  T. Cloughesy,et al.  Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma , 2012, American Journal of Neuroradiology.

[17]  Hayit Greenspan,et al.  Automated temporal tracking and segmentation of lymphoma on serial CT examinations. , 2011, Medical physics.

[18]  Olivier Gevaert,et al.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. , 2012, Radiology.

[19]  Hiroshi Tanaka,et al.  Distinct clinicopathological phenotype of hepatocellular carcinoma with ethoxybenzyl-magnetic resonance imaging hyperintensity: association with gene expression signature. , 2015, American journal of surgery.

[20]  A. Shelling,et al.  Predictive and prognostic molecular markers for cancer medicine , 2010, Therapeutic advances in medical oncology.

[21]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[22]  Chaya S Moskowitz,et al.  From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements? , 2015, Lung cancer.

[23]  Osamu Matsui,et al.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.

[24]  Howard Y. Chang,et al.  Decoding global gene expression programs in liver cancer by noninvasive imaging , 2007, Nature Biotechnology.

[25]  Neema Jamshidi,et al.  Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. , 2013, Radiology.

[26]  C. Jaffe.  Imaging and genomics: is there a synergy? , 2012, Radiology.

[27]  D. D. Maki,et al.  Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape. , 2012, AJR. American journal of roentgenology.

[28]  Pascal O. Zinn,et al.  A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature , 2012, PloS one.

[29]  Matthew A. Zapala,et al.  The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma. , 2015, Radiology.

[30]  Ru-Fang Yeh,et al.  Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. , 2010, Radiology.

[31]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[32]  Ben Glocker,et al.  Decision Forests for Tissue-Specific Segmentation of High-Grade Gliomas in Multi-channel MR , 2012, MICCAI.

[33]  Peter J. Ell,et al.  Multifunctional Imaging Signature for V-KI-RAS2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations in Colorectal Cancer , 2014, The Journal of Nuclear Medicine.

[34]  M. Kuo,et al.  Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations. , 2014, Radiology.

[35]  A. Bozzao,et al.  Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status , 2013, European Radiology.

[36]  J. Ule,et al.  Protein–RNA interactions: new genomic technologies and perspectives , 2012, Nature Reviews Genetics.

[37]  D. Longo,et al.  Tumor heterogeneity and personalized medicine. , 2012, The New England journal of medicine.

[38]  R. Jain,et al.  Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study , 2012, American Journal of Neuroradiology.

[39]  David Gutman,et al.  Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. , 2013, Radiology.

[40]  T. Cloughesy,et al.  Probabilistic Radiographic Atlas of Glioblastoma Phenotypes , 2013, American Journal of Neuroradiology.

[41]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[42]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[43]  Tracy T Batchelor,et al.  Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in Glioblastoma , 2005, Clinical Cancer Research.

[44]  D. Kong,et al.  Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status , 2011, American Journal of Neuroradiology.

[45]  H. Hricak,et al.  Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. , 2013, Radiology.

[46]  Sylvia Drabycz,et al.  An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging , 2010, NeuroImage.

[47]  Philippe Bertrand,et al.  Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma , 2012, Leukemia & lymphoma.

[48]  Daniel R. Weinberger,et al.  Imaging genetics—days of future past , 2010, NeuroImage.

[49]  Max Wintermark,et al.  Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project , 2014, BMC Medical Genomics.

[50]  Keith L. Ligon,et al.  Somatic mutations associated with MRI-derived volumetric features in glioblastoma , 2015, Neuroradiology.

[51]  Hersh Chandarana,et al.  Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? , 2011, AJR. American journal of roentgenology.

[52]  A. Gupta,et al.  Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification , 2015, Clinical Neuroradiology.

[53]  Honghao Zhou,et al.  Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment. , 2015, Carcinogenesis.

[54]  Ahmed Bilal Ashraf,et al.  Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. , 2014, Radiology.

[55]  Shaowu Li,et al.  Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas , 2014, Journal of the Neurological Sciences.

[56]  Benjamin M Ellingson,et al.  Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. , 2013, Neuro-oncology.

[57]  Mithat Gonen,et al.  18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis , 2010, Journal of Nuclear Medicine.

[58]  Maciej A Mazurowski,et al.  Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.

[59]  S. Li,et al.  Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel‐based radiographic study of 146 low‐grade gliomas , 2015, European journal of neurology.

[60]  Koenraad Van Leemput,et al.  Segmentation of image ensembles via latent atlases , 2010, Medical Image Anal..

[61]  Joseph O. Deasy,et al.  Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay , 2015, Journal of magnetic resonance imaging : JMRI.

[62]  Lars J. Grimm,et al.  Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms , 2015, Journal of magnetic resonance imaging : JMRI.

[63]  Robert G. Uzzo,et al.  Heterogeneity and renal mass biopsy: a review of its role and reliability , 2014, Cancer biology & medicine.

[64]  K. Aldape,et al.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules , 2008, Proceedings of the National Academy of Sciences.

[65]  Kaori Togashi,et al.  Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer , 2012, Clinical Cancer Research.

[66]  P. Visscher,et al.  Pitfalls of predicting complex traits from SNPs , 2013, Nature Reviews Genetics.

[67]  E. Mardis,et al.  Analysis of next-generation genomic data in cancer: accomplishments and challenges. , 2010, Human molecular genetics.

[68]  Antti Honkela,et al.  A Generative Approach for Image-Based Modeling of Tumor Growth , 2011, IPMI.

[69]  Michelle S. Ginsberg,et al.  Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features? , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[70]  Li Lan,et al.  Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers. , 2014, Medical physics.

[71]  Erich P Huang,et al.  Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas–Renal Cell Carcinoma (TCGA–RCC) Imaging Research Group , 2015, Abdominal Imaging.

[72]  Jae-Hun Kim,et al.  Imaging-Based Tumor Treatment Response Evaluation: Review of Conventional, New, and Emerging Concepts , 2012, Korean journal of radiology.

[73]  M. Mazurowski.  Radiogenomics: what it is and why it is important. , 2015, Journal of the American College of Radiology : JACR.

[74]  Richard D. White,et al.  CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. , 2015, AJR. American journal of roentgenology.

[75]  Leonard Sunwoo,et al.  Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS‐MLPA in patients with glioblastoma multiforme , 2013, Journal of magnetic resonance imaging : JMRI.

[76]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[77]  Christos Davatzikos,et al.  GLISTR: Glioma Image Segmentation and Registration , 2012, IEEE Transactions on Medical Imaging.

[78]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  Massimo Bellomi,et al.  CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer , 2015, European Radiology.

[80]  Tae Joo Jeon,et al.  Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients , 2016, Medicine.

[81]  Catherine Dumur,et al.  Microarray Analysis of MRI-defined Tissue Samples in Glioblastoma Reveals Differences in Regional Expression of Therapeutic Targets , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[82]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[83]  Peng-Fei Li,et al.  Brain metastasis in children with stage 4 neuroblastoma after multidisciplinary treatment , 2015, Chinese journal of cancer.

[84]  W. Moon,et al.  Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging , 2012, Neuroradiology.

[85]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[86]  S. Heiland,et al.  IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma , 2015, Scientific Reports.

[87]  Jeannie T. Lee,et al.  Long Noncoding RNAs: Past, Present, and Future , 2013, Genetics.

[88]  Neema Jamshidi,et al.  Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis. , 2015, Radiology.

[89]  David A Gutman,et al.  Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. , 2015, Radiology.

[90]  Se Hoon Kim,et al.  Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. , 2014, Journal of neurosurgery.

[91]  N. Thacker,et al.  Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.

[92]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[93]  Olivier Gevaert,et al.  Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. , 2015, Journal of neuroradiology. Journal de neuroradiologie.

[94]  Chris Sander,et al.  18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. , 2011, Cancer research.

[95]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[96]  M. Kuo,et al.  Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. , 2007, Journal of vascular and interventional radiology : JVIR.

[97]  E. Sala,et al.  Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? , 2012, The British journal of radiology.

[98]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[99]  S. Plevritis,et al.  Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. , 2014, Radiology.

[100]  Yuka Yamamoto,et al.  Molecular Mechanism Underlying the Detection of Colorectal Cancer by 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography , 2012, Journal of Gastrointestinal Surgery.

[101]  Ferenc A. Jolesz,et al.  Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme , 2011, PloS one.